Focused Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.89M | Buy |
119,833
+4,575
| +4% | +$120K | 0.25% | 49 |
|
|
2026
Q1 | $3.24M | Buy |
115,258
+5,541
| +5% | +$148K | 0.34% | 44 |
|
|
2025
Q4 | $2.73M | Sell |
109,717
-266
| -0.2% | -$6.71K | 0.29% | 46 |
|
|
2025
Q3 | $2.8M | Buy |
109,983
+1,511
| +1% | +$37.3K | 0.3% | 43 |
|
|
2025
Q2 | $2.63M | Buy |
108,472
+2,862
| +3% | +$66.7K | 0.32% | 42 |
|
|
2025
Q1 | $2.68M | Buy |
105,610
+9,429
| +10% | +$247K | 0.36% | 36 |
|
|
2024
Q4 | $2.55M | Sell |
96,181
-8,515
| -8% | -$231K | 0.34% | 36 |
|
|
2024
Q3 | $3.03M | Sell |
104,696
-608
| -0.6% | -$17.7K | 0.39% | 38 |
|
|
2024
Q2 | $2.95M | Sell |
105,304
-13,379
| -11% | -$368K | 0.42% | 32 |
|
|
2024
Q1 | $3.29M | Sell |
118,683
-15,052
| -11% | -$418K | 0.51% | 33 |
|
|
2023
Q4 | $3.85M | Buy |
133,735
+33,184
| +33% | +$1M | 0.63% | 28 |
|
|
2023
Q3 | $3.34M | Buy |
100,551
+9,989
| +11% | +$353K | 0.59% | 30 |
|
|
2023
Q2 | $3.32M | Buy |
90,562
+15,519
| +21% | +$604K | 0.6% | 29 |
|
|
2023
Q1 | $3.06M | Sell |
75,043
-2,580
| -3% | -$111K | 0.62% | 27 |
|
|
2022
Q4 | $3.98M | Buy |
77,623
+602
| +0.8% | +$28.9K | 0.81% | 23 |
|
|
2022
Q3 | $3.37M | Sell |
77,021
-19,527
| -20% | -$949K | 0.71% | 25 |
|
|
2022
Q2 | $5.06M | Sell |
96,548
-5,258
| -5% | -$268K | 0.92% | 20 |
|
|
2022
Q1 | $5.27M | Sell |
101,806
-2,512
| -2% | -$130K | 0.83% | 23 |
|
|
2021
Q4 | $6.16M | Buy |
104,318
+1,811
| +2% | +$89.7K | 0.95% | 20 |
|
|
2021
Q3 | $4.41M | Buy |
102,507
+1,169
| +1% | +$51.8K | 0.72% | 24 |
|
|
2021
Q2 | $3.97M | Buy |
101,338
+1,287
| +1% | +$50K | 0.65% | 24 |
|
|
2021
Q1 | $3.63M | Buy |
100,051
+17,920
| +22% | +$636K | 0.64% | 23 |
|
|
2020
Q4 | $3.02M | Buy |
82,131
+10,073
| +14% | +$369K | 0.59% | 26 |
|
|
2020
Q3 | $2.51M | Sell |
72,058
-739
| -1% | -$25.9K | 0.55% | 28 |
|
|
2020
Q2 | $2.26M | Buy |
72,797
+2,885
| +4% | +$98K | 0.52% | 28 |
|
|
2020
Q1 | $2.17M | Buy |
69,912
+837
| +1% | +$28.5K | 0.62% | 24 |
|
|
2019
Q4 | $2.57M | Buy |
69,075
+550
| +0.8% | +$19.6K | 0.61% | 27 |
|
|
2019
Q3 | $2.34M | Sell |
68,525
-564
| -0.8% | -$20.5K | 0.65% | 26 |
|
|
2019
Q2 | $2.84M | Sell |
69,089
-143
| -0.2% | -$5.68K | 0.76% | 21 |
|
|
2019
Q1 | $2.79M | Sell |
69,232
-1,443
| -2% | -$57.8K | 0.84% | 20 |
|
|
2018
Q4 | $2.93M | Sell |
70,675
-17,629
| -20% | -$732K | 1% | 20 |
|
|
2018
Q3 | $3.69M | Buy |
88,304
+54,433
| +161% | +$2.1M | 1.26% | 17 |
|
|
2018
Q2 | $1.17M | Sell |
33,871
-2,929
| -8% | -$100K | 0.4% | 47 |
|
|
2018
Q1 | $1.24M | Buy |
36,800
+4,114
| +13% | +$141K | 0.4% | 44 |
|
|
2017
Q4 | $1.12M | Buy |
32,686
+311
| +1% | +$10.6K | 0.36% | 44 |
|
|
2017
Q3 | $1.1M | Buy |
32,375
+455
| +1% | +$14.6K | 0.37% | 46 |
|
|
2017
Q2 | $1.02M | Buy |
31,920
+4,664
| +17% | +$147K | 0.38% | 43 |
|
|
2017
Q1 | $885K | Buy |
27,256
+140
| +0.5% | +$4.41K | 0.35% | 51 |
|
|
2016
Q4 | $836K | Buy |
27,116
+287
| +1% | +$8.76K | 0.35% | 44 |
|
|
2016
Q3 | $862K | Buy |
26,829
+54
| +0.2% | +$1.81K | 0.38% | 41 |
|
|
2016
Q2 | $894K | Buy |
26,775
+718
| +3% | +$22.9K | 0.41% | 41 |
|
|
2016
Q1 | $733K | Buy |
26,057
+11,903
| +84% | +$340K | 0.4% | 45 |
|
|
2015
Q4 | $433K | Buy |
14,154
+398
| +3% | +$12.5K | 0.25% | 68 |
|
|
2015
Q3 | $410K | Buy |
13,756
+130
| +1% | +$4.17K | 0.26% | 64 |
|
|
2015
Q2 | $433K | Sell |
13,626
-1,442
| -10% | -$47K | 0.27% | 62 |
|
|
2015
Q1 | $497K | Buy |
15,068
+195
| +1% | +$6.2K | 0.31% | 61 |
|
|
2014
Q4 | $440K | Buy |
14,873
+214
| +1% | +$6.14K | 0.31% | 62 |
|
|
2014
Q3 | $411K | Buy |
14,659
+3,440
| +31% | +$96.5K | 0.32% | 66 |
|
|
2014
Q2 | $316K | Buy |
11,219
+774
| +7% | +$22.1K | 0.25% | 68 |
|
|
2014
Q1 | $318K | Sell |
10,445
-73
| -0.7% | -$2.18K | 0.27% | 64 |
|
|
2013
Q4 | $306K | Buy |
10,518
+296
| +3% | +$8.62K | 0.26% | 70 |
|
|
2013
Q3 | $279K | Buy |
+10,222
| New | +$278K | 0.27% | 65 |
|
Other funds holding PFE
Focused Wealth Management's PFE Position: Q2 2026 in Review
Focused Wealth Management increased its Pfizer (PFE) stake by 4% in Q2 2026, buying an estimated $120K and bringing the position to 119,833 shares worth $2.89M. The position accounts for 0.25% of the portfolio, ranked #49.
Focused Wealth Management first reported a position in PFE in Q3 2013 and has held it in 52 quarters since. The position peaked at $6.16M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Focused Wealth Management held 119,833 shares of Pfizer worth $2.89M as of Q2 2026.
- Focused Wealth Management bought 4,575 Pfizer shares in Q2 2026, an estimated $120K.
- Pfizer made up 0.25% of Focused Wealth Management's portfolio in Q2 2026, its #49 holding.
- Focused Wealth Management first reported a position in Pfizer in Q3 2013 and has held it in 52 quarters since.
- Focused Wealth Management's Pfizer position peaked at $6.16M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Focused Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.